Myriad Genetics (MYGN) Advances in MRD Space With New Patent - Zacks Investment Research
Myriad Genetics Inc · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $4.28
+12% in 7d after detection
Post-detection moves
1h
—
1d
+7.3%
3d
+7.6%
7d
+12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS